Related Experiment Videos
APOE and APOC1 genetic polymorphisms in age-associated memory impairment
D Bartrés-Faz1, I C Clemente, C Junqué
1Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Spain. dbatres@psi.ub.es
Neurogenetics
|November 21, 2001
Summary
Genetic variations in APOE and APOC1 are linked to age-associated memory impairment (AAMI). This study suggests a genetic basis for memory decline in aging individuals, highlighting APOC1 for future research.
Area of Science:
- Neurogenetics
- Cognitive Aging Research
Background:
- Age-associated memory impairment (AAMI) affects a significant portion of the aging population.
- Understanding the genetic underpinnings of memory decline is crucial for developing targeted interventions.
Purpose of the Study:
- To investigate the association of APOE and APOC1 genetic polymorphisms with age-associated memory impairment (AAMI).
- To determine if individuals meeting NIMH criteria for AAMI are genetically distinct from normally aging controls regarding these polymorphisms.
Main Methods:
- Genotyping of APOE and APOC1 polymorphisms in 100 subjects with AAMI and 124 healthy controls.
- Statistical analysis to assess the association between genetic loci, their combinations, and the AAMI condition.
Main Results:
- Significant associations were found between both APOE and APOC1 loci, and their combined genotypes, with AAMI.
- The study sample indicated genetic differentiation between memory-impaired and normally aging individuals concerning these specific polymorphisms.
Conclusions:
- APOE and APOC1 gene variations are associated with age-associated memory impairment.
- These findings suggest a genetic component to AAMI and warrant further investigation into the APOC1 gene's role in cognitive aging.